Brassai Attila | Best Academic Researcher Award | Phamacology

Best Academic Researcher Award

Brassai Attila
University of Medicine, Pharmacy, Science and Technology G E Palade Targu-Mures, Romania

Brassai Attila
Affiliation University of Medicine, Pharmacy, Science and Technology G E Palade Targu-Mures
Country Romania
scoupus ID 16164899700
Documents 13
Citations 311
h-index 5
Subject Area Phamacology
Event International Academic Achievements & Awards

Brassai Attila is presented for academic recognition in connection with research interests spanning structured decision-making, complex-product service systems, matching frameworks and analytical approaches to provider selection. The supplied research topic, “Selecting after sales provider of complex product based on game and matching framework,” concerns the design of an analytical framework for selecting after-sales service providers for complex products. The indexed article associated with this title was published in Engineering Applications of Artificial Intelligence in 2025 and is identified with DOI 10.1016/j.engappai.2025.112524. [1]

Abstract

This academic recognition profile examines the research context supplied for Brassai Attila and its relationship to contemporary analytical approaches for complex-product after-sales services. The featured research topic addresses provider selection through a combination of game-theoretic reasoning and matching mechanisms. The published study develops a framework in which strategic interaction between an original equipment manufacturer and an after-sales service provider is considered alongside criteria for matching service capabilities with product or spare-part requirements. The study reports the use of a Stackelberg game, entropy-weighted DEMATEL analysis and a two-sided matching model to connect participation incentives, evaluation attributes and provider selection. [1]

The research theme is relevant to decision sciences, industrial engineering, service management and supply-chain research because complex products require coordinated technical support throughout extended product life cycles. The available bibliographic evidence supports the description of these methodological themes, while researcher-specific bibliometric indicators should be obtained directly from the linked scholarly profiles before publication as verified metrics. [1]

Keywords

  • Best Academic Researcher Award
  • Complex Products
  • After-Sales Service
  • Provider Selection
  • Game Theory
  • Two-Sided Matching
  • Supply Chain Management
  • Decision Analysis

Introduction

Complex products are characterized by substantial technical requirements, long development or service cycles and interactions among multiple organizations. Their after-sales phase can therefore involve specialized maintenance, spare-parts coordination, technical support, quality management and provider governance. Research on service-provider selection seeks to formalize these decisions so that organizational requirements and provider capabilities can be evaluated systematically.

The supplied research topic approaches this problem through game theory and matching analysis. The indexed study frames the relationship between an original equipment manufacturer and an after-sales service provider as a strategic interaction and subsequently incorporates provider attributes into a matching process. The reported framework therefore connects strategic incentives with operational selection rather than treating provider selection as a simple single-criterion procurement decision. [1]

Research Profile

The supplied profile places Brassai Attila at the University of Medicine, Pharmacy, Science and Technology G E Palade Targu-Mures in Romania. A Google Scholar identifier and an ORCID identifier were supplied for profile-level identification. The corresponding Scopus author identifier supplied for the profile is 16164899700. Because bibliometric values can change over time and were not independently established from the available public records used for this article, documents, citations and h-index are not stated as verified numerical values.

The research material supplied for this recognition profile is situated around analytical decision-making for complex-product after-sales services. The principal methodological concepts appearing in the indexed publication include Stackelberg game modelling, entropy-weighted DEMATEL analysis and two-sided matching. [1]

Research Contributions

The supplied research topic is associated with several methodological contributions relevant to complex-product service management:

  • Integration of strategic interaction and provider-selection analysis within a common analytical framework.
  • Use of a Stackelberg game to examine participation incentives and interactions between an original equipment manufacturer and an after-sales service provider.
  • Application of entropy-weighted DEMATEL to examine the relative importance and causal relationships of evaluation attributes.
  • Use of two-sided matching logic to connect provider capabilities with complex-product service requirements.
  • Development of a structured decision process intended to support the evaluation and selection of after-sales service providers.

These elements are documented in the indexed publication record and provide a basis for considering the supplied research theme within decision analysis, industrial engineering and service-oriented supply-chain research. [1][2]

Research Impact

The research theme represented by the supplied publication addresses a practical decision problem in the management of complex products: how an organization can evaluate and select an after-sales service provider while accounting for strategic relationships and multiple assessment criteria. The article describes an integrated approach in which provider participation, attribute evaluation and matching are considered within a connected analytical structure. [1]

Such analytical approaches may be relevant to organizations managing high-value or technically complex assets because service-provider selection can involve technical capability, compatibility, incentives, quality supervision and other interdependent considerations. The available publication record supports these methodological and application-oriented observations, while direct evidence of institutional or industrial adoption should be evaluated separately from the publication itself. [1]

Award Suitability

The Best Academic Researcher Award recognition profile can document research activity through identifiable scholarly records, methodological contributions and relevance to an established academic field. For a formal award assessment, the researcher’s authorship, publication record, citation information, institutional affiliation and scholarly identifiers should be verified against the corresponding primary or authoritative academic sources.

In the present profile, the supplied Google Scholar, Scopus and ORCID identifiers provide routes for further verification. The available publication evidence establishes the relevance of the featured research topic to analytical provider selection and complex-product service management, but it does not by itself establish that Brassai Attila is an author of the cited article. This distinction is retained to preserve bibliographic accuracy.

Conclusion

Brassai Attila is presented in this academic recognition profile in association with the University of Medicine, Pharmacy, Science and Technology G E Palade Targu-Mures, Romania, and with supplied scholarly identifiers. The research theme provided for the profile concerns the analytical selection of after-sales service providers for complex products using game-theoretic and matching approaches. The identified 2025 publication provides a documented example of this research theme and demonstrates the use of structured analytical methods for complex service-provider selection. [1]

For publication as a verified researcher biography, numerical bibliometric indicators and publication authorship should be checked directly against the linked scholarly profiles and authoritative publication records. This approach keeps the recognition page academically transparent while distinguishing supplied profile information from independently verifiable bibliographic evidence.

References

  1. The role of the vesicular monoamine transporter 2 in the inhibitory effect of tetrabenazine and valbenazine compared to reserpine on the vesicular release of monoamine transmitters
    https://www.scopus.com/authid/detail.uri?authorId=16164899700
  2. Role of synaptic and nonsynaptic glutamate receptors in ischaemia induced neurotoxicity
    https://scholar.google.com/citations?view_op=view_citation&hl=en&user=OHUOnrYAAAAJ&citation_for_view=OHUOnrYAAAAJ:UeHWp8X0CEIC

Neeraj Thakur | Pharmacology | Innovative Research Award

Innovative Research Award

Neeraj Thakur
Affiliation University of Oklahoma Health Campus
Country United States
Scopus ID 56645996700
Documents 37
Citations 1,149
h-index 20
Subject Area Pharmacology, Toxicology and Pharmaceutical Science
Event International Academic Achievements & Awards
ORCID 0000-0003-1758-0737

Neeraj Thakur
University of Oklahoma Health Campus, United States

The Innovative Research Award recognizes sustained scholarly excellence, impactful scientific contributions, and innovation in biomedical and pharmaceutical sciences. Neeraj Thakur has established an active research profile focused on advanced drug delivery systems, nanomedicine, pharmaceutical formulations, biomaterials, and translational therapeutic technologies. His published work demonstrates interdisciplinary collaboration across pharmaceutical science, toxicology, and biomedical engineering while contributing to improved therapeutic delivery strategies for dermatological and ocular applications.[1]

Abstract

Neeraj Thakur’s research integrates pharmaceutical sciences, nanotechnology, biomaterials, and targeted therapeutic delivery to address challenges associated with drug stability, controlled release, tissue targeting, and improved clinical efficacy. His work encompasses hybrid micellar systems, ocular nanoformulations, RNA interference technologies, and advanced pharmaceutical carriers designed to improve patient outcomes through innovative formulation strategies.[2]

Keywords

Drug Delivery Systems, Nanomedicine, Hybrid Micelles, RNA Interference, Corneal Therapeutics, Pharmaceutical Sciences, Targeted Drug Delivery

Introduction

Modern pharmaceutical research increasingly focuses on precision drug delivery, sustained therapeutic release, and biomaterial-enabled treatment strategies. Neeraj Thakur’s research aligns with these objectives through the development of multifunctional nanocarriers and advanced pharmaceutical formulations capable of enhancing therapeutic performance while minimizing adverse effects. His publications demonstrate an interdisciplinary approach combining pharmaceutical sciences with materials engineering and translational medicine.[3]

Research Profile

  • Scopus Author ID: 56645996700
  • 37 indexed scholarly publications.
  • 1,149 citations reflecting broad scientific visibility.
  • h-index of 20 demonstrating consistent research influence.
  • Research spans pharmacology, toxicology, pharmaceutical sciences, nanomedicine and biomaterials.

Research Contributions

The research contributions of Neeraj Thakur include the design of crosslinked hybrid micellar systems for cutaneous drug delivery, sustained nanoformulations for corneal wound healing, and RNA interference applications in viral diagnostics and therapeutics. These investigations emphasize formulation optimization, targeted delivery, therapeutic efficiency, and translational biomedical applications while supporting the broader advancement of pharmaceutical technology.[4]

Publications

  • Crosslinked hybrid micellar platform for targeted cutaneous drug delivery
    Colloids and Surfaces B: Biointerfaces (2026). DOI: 10.1016/j.colsurfb.2026.115998
  • Crosslinked Hybrid Micellar Platform for Targeted Cutaneous Drug Delivery
    Preprint (2026). DOI: 10.2139/ssrn.6250431
  • A multimodal approach to smart and sustained drug delivery for corneal wound management: the GelPol nanoformulation
    Nanomedicine (2025). DOI: 10.1080/17435889.2025.2550236
  • RNAi in viral control and diagnostics
    Book Chapter (2025). DOI: 10.1088/978-0-7503-4987-1ch12

Research Impact

The documented citation profile, publication record, and interdisciplinary research portfolio indicate sustained academic influence within pharmaceutical sciences. Contributions toward targeted drug delivery technologies and nanomedicine support ongoing developments in precision therapeutics, controlled release formulations, and biomedical innovation. The citation metrics further demonstrate recognition by the international research community.[1]

Award Suitability

Based on the available scholarly metrics, publication output, interdisciplinary research contributions, and demonstrated impact within pharmaceutical sciences, Neeraj Thakur represents a suitable candidate for recognition through the Innovative Research Award. His research portfolio reflects innovation in drug delivery technologies, sustained scientific productivity, and contributions supporting future translational healthcare solutions.[2]

Conclusion

Neeraj Thakur has established a notable research profile characterized by innovation in pharmaceutical formulation science, targeted therapeutic delivery, nanotechnology, and biomaterial-based treatment strategies. Supported by strong bibliometric indicators and peer-reviewed scholarly publications, his work contributes to the continued advancement of pharmaceutical sciences and biomedical research while reflecting the qualities recognized by the Innovative Research Award.[4]

References

  1. Elsevier. (n.d.). Scopus author details: Neeraj Thakur, Author ID 56645996700. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=56645996700
  2. Thakur, N. (2026). Crosslinked hybrid micellar platform for targeted cutaneous drug delivery. Colloids and Surfaces B: Biointerfaces.
    https://doi.org/10.1016/j.colsurfb.2026.115998
  3. Thakur, N. (2026). Crosslinked Hybrid Micellar Platform for Targeted Cutaneous Drug Delivery. SSRN Preprint. https://doi.org/10.2139/ssrn.6250431
  4. Thakur, N. (2025). A multimodal approach to smart and sustained drug delivery for corneal wound management: the GelPol nanoformulation. Nanomedicine. https://doi.org/10.1080/17435889.2025.2550236
  5. Thakur, N. (2025). RNAi in viral control and diagnostics. Viral Diseases: History and New Developments in Diagnostics and Therapeutics.
    https://doi.org/10.1088/978-0-7503-4987-1ch12

Stuart Maudsley | Pharmacology | Best Researcher Award

Prof. Dr. Stuart Maudsley | Pharmacology | Best Researcher Award

Prof. Dr. Stuart Maudsley | Pharmacology – Professor at Moffitt Cancer Center, United States

Dr. Stuart Russell Maudsley is an esteemed researcher and principal investigator whose work has had a profound impact on the field of pharmacology, particularly in the study of G-protein-coupled receptors (GPCRs). His career has been marked by significant contributions to cancer research, aging, and molecular gerontology, leading to the development of innovative therapeutic strategies aimed at treating complex human diseases. Dr. Maudsley’s work focuses on the precision targeting of GPCRs to develop treatments for a wide range of conditions, from cancer to neurodegenerative disorders, with a unique approach that blends basic science with clinical applications. He has been instrumental in leading transformative research at Moffitt Cancer Center and has earned widespread recognition for his contributions in both academia and industry.

Profile:

Scopus

Education:


Dr. Maudsley earned his Ph.D. in Pharmacology from the University of Leeds, UK, after completing a First-Class Bachelor’s degree in Pharmacology at the same institution. His doctoral research focused on electrophysiological and molecular biological studies of Tachykinin receptors, which set the stage for his continued exploration of receptor biology. His academic journey laid the groundwork for a career dedicated to uncovering the complex molecular mechanisms that regulate cellular behavior and how these processes can be manipulated for therapeutic purposes. His early education and research provided a foundation for his later innovations in the field of pharmacology and receptor therapeutics.

Experience:


Dr. Maudsley’s career spans several prestigious roles that highlight his leadership and expertise in pharmacology and receptor biology. He currently serves as the principal investigator at Moffitt Cancer Center, where he directs the Maudsley Lab, focusing on receptor biology and cancer therapeutics. His work is particularly notable for its precision in targeting GPCRs to treat cancer and other complex diseases. Dr. Maudsley also co-founded HeptOME – Receptor Therapeutics, and his position as a Special Science Advisor for the Belgian Superior Health Council reflects his international influence. His experience in both academic and industry settings has allowed him to bridge the gap between cutting-edge research and real-world therapeutic solutions.

Research Interests:


Dr. Maudsley’s primary research interest lies in the molecular and pharmacological study of GPCRs, a class of receptors that play a crucial role in various cellular processes. He focuses on understanding how these receptors regulate human diseases, particularly cancer, aging, and neurodegenerative disorders. By investigating the intricate mechanisms of GPCR signaling, Dr. Maudsley aims to develop novel targeted therapies that can improve treatment outcomes in these complex diseases. His research extends to systems pharmacology, which integrates multidimensional approaches to identify new drug targets and improve therapeutic strategies. Dr. Maudsley is particularly interested in the therapeutic application of GPCR-targeted medicines and their potential to treat diseases with unmet medical needs.

Awards:


Dr. Maudsley has received numerous accolades for his pioneering research in pharmacology and receptor biology. His work has been consistently recognized for its potential to revolutionize therapeutic strategies for cancer and aging-related diseases. He has been invited to speak at prestigious international conferences and has received several awards from scientific and medical societies for his contributions to understanding receptor biology. His recognition as a co-founder of HeptOME – Receptor Therapeutics further highlights his entrepreneurial spirit and ability to translate scientific discoveries into practical applications that benefit patients worldwide.

Publications:


Dr. Maudsley has an extensive publication record, contributing to major scientific journals and collaborative research projects. A few notable publications include:

  1. Maudsley S., Leysen H., van Gastel J., Martin B. (2021). Systems Pharmacology: Enabling Multidimensional Therapeutics, Reference Module in Biomedical Sciences. 📖
  2. Maudsley S., Schrauwen C., Harputluoğlu İ., Walter D., Leysen H., McDonald P. (2023). GPR19 Coordinates Multiple Molecular Aspects of Stress Responses Associated with the Aging Process, Int J Mol Sci. 🔬
  3. Schreurs G., Maudsley S., Nast C., Praet M., Da Silva Fernandes S., Boor P., D’Haese P., De Broe M.E., Vervaet B.A. (2023). Chronic Dehydration Induces Injury Pathways in Rats, Sci Rep. 🧪
  4. Maudsley S., Leysen H., Walter D., Vandoren R. (2023). GPCRs Regulate DNA Integrity, Encyclopedia – Biochemistry and Molecular Biology. 📑
  5. Coppens V., De Wachter O., Goossens J., Hendrix J., Maudsley S., Azmi A., van Gastel J., Van Saet A., Lauwers T., Morrens M. (2020). Profiling of Peripheral Blood Mononuclear Cells for Schizophrenia Biomarkers, Neuropsychobiology. 🧠
  6. Van Meenen J., Leysen H., Chen H., Baccarne R., Walter D., Martin B., Maudsley S. (2022). Making Biomedical Sciences Publications More Accessible for Machines, Med Health Care Philos. 💻
  7. Leysen H., Maudsley S., Van Gastel J., Martin B. (2021). The RXFP3 Receptor is a Modulator of Aging-Related Disease, Int J Mol Sci. 🧬

Conclusion:


Dr. Stuart Russell Maudsley’s extensive contributions to pharmacology, especially in the area of GPCRs and their role in complex diseases, make him an exceptional candidate for the Best Researcher Award. His research, which bridges the gap between basic science and clinical applications, continues to shape the future of precision medicine. Through his innovative work at Moffitt Cancer Center and his involvement in entrepreneurial ventures like HeptOME – Receptor Therapeutics, Dr. Maudsley has made a lasting impact on both academia and industry. His leadership in the field and his commitment to advancing therapeutic solutions for cancer, aging, and neurodegenerative diseases position him as a truly deserving nominee for this prestigious award.